BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Daewoong Pharmaceutical’s Bersiporocin Clears Third IDMC Safety Review, Global Phase 2 IPF Trial to Continue

Third Independent Data Monitoring Committee (IDMC) review confirms safety and continuation of the study 94 patients enrolled out of 102 planned across K...

October 28, 2025 | News

Nielsen BioSciences and Maruho Expand Licensing Agreement for CANDIN Across Key Asian Markets

Expansion of licensing agreement extends CANDIN’s development to key Asian growth markets including China, South Korea and Taiwan--and broadens the...

October 27, 2025 | News

Samsung Bioepis and Phrontline Partner to Develop Next-Generation Bispecific, Dual-Payload ADC Therapies for Solid Tumours

Samsung Bioepis and Phrontline will co-develop two investigational antibody-drug conjugate (ADC) assets directed against targets expressed in a broad r...

October 22, 2025 | News

SK Bioscience Files Clinical Trial Application in Australia for GBP511 Universal Coronavirus Vaccine

Candidate designed to protect against COVID-19 variants and broader Sarbecoviruses Phase 1/2 study to enroll ~500 healthy adults, with topline results e...

October 16, 2025 | News

Building Biopharma Resilience: Cytiva’s Joonho Choi on the Power of Connected Ecosystems

Amid global supply chain disruptions, tightening regulations, and shifting patient needs, biopharma resilience has become both a stra...

October 15, 2025 | Interview

GC Biopharma Secures Global CMO Rights for Curevo’s Recombinant Shingles Vaccine

GC Biopharma (006280.KS), a South Korean biopharmaceutical company, announced that it has signed an agreement with Curevo Vaccine to secure contract manufa...

October 14, 2025 | News

South Korean Vaxcellbio Secures Australian Patent for Next-Generation NK Cell Expansion Technology

Vaxcellbio (CEO Je-Jung Lee, MD, PhD ), a biotechnology company specializing in immuno-oncology, announced ,that it has successfully obtained an Aust...

October 14, 2025 | News

Celltrion Receives FDA Approval for EYDENZELT®, a Biosimilar to EYLEA® for Retinal Diseases

EYDENZELT® is approved for the treatment of patients with neovascular (wet) age-related macular degeneration (wAMD), macular edema following ret...

October 13, 2025 | News

Leading Scientists Unite at OrganoAsia 2a025 to Advance Organoid Research and Industrial Applications

Leading Scientists from China, Japan and South Korea Convene to Drive Organoid Research and Commercialization ACROBiosystems, tog...

October 13, 2025 | Report

Samsung Biologics Launches ExellenS™ Framework to Standardise and Accelerate Global Biomanufacturing

ExellenS TM applies optimized facility designs, equipment, and processes across all sites to ensure equivalency and speed ExellenS TM&nbs...

October 10, 2025 | News

Asia-Pacific Takes the Lead in Global Biopharma Resilience: Cytiva’s 2025 Index Highlights Regional Rise Amid Global Slowdown

The 2025 Global Biopharma Index released by Cytiva, a Danaher company, reveals that while the global biopharma ecosystem has experienced a modest decline i...

October 08, 2025 | Analysis

Celltrion Launches AVTOZMA IV FDA Approved Tocilizumab Biosimilar in United States

The AVTOZMA® (tocilizumab-anoh) intravenous (IV) formulation was approved in January 2025 by the FDA to treat the same conditions as t...

October 03, 2025 | News

COREE Identifies First-Ever Microbiome Biomarkers for Diabetes and Obesity Patients

COREE announced on September 15 that it had, for the first time in the world, identified microbiome biomarkers specific to diabetes and obesity p...

September 29, 2025 | News

Thermo Fisher Partners With South Korea’s Dr. Park CDMO To Deliver Advanced Bioprocessing Solutions For Large-Scale Cell And Gene Therapy Production

Advanced bioprocessing solutions from Thermo Fisher to support large-scale production and global access to cell and gene therapies Thermo Fisher Scientifi...

September 26, 2025 | News

Stay Connected